Stay updated on XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial

Sign up to get notified when there's something new on the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    A notice about NIH websites and terminology appears above the ClinicalTrials.gov 403 error page. The site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T16:35:23.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-13T17:32:43.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the detailed record. The trial information and navigation are no longer accessible, leaving only the site header and error message.
    Difference
    18%
    Check dated 2026-09-22T22:09:06.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.6 to v3.7.0. This indicates a deployment or template update rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-09-15T22:16:48.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page's revision identifier was updated from v3.6.5 to v3.6.6, indicating a new version of the page. This update does not alter the study details presented on the page.
    Difference
    0.1%
    Check dated 2026-09-01T18:21:06.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the page template. This change does not alter the study details, eligibility criteria, or results presented on the page.
    Difference
    0.1%
    Check dated 2026-08-11T14:34:33.000Z thumbnail image

Stay in the know with updates to XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XMT-1592 Study in NaPi2b+ Ovarian Cancer & NSCLC Clinical Trial page.